Seeking Alpha

Sequenom (SQNM) surged 9.4% today after a Wedbush analyst said results for its Maternit21 fetal...

Sequenom (SQNM) surged 9.4% today after a Wedbush analyst said results for its Maternit21 fetal genetic tests make it harder to argue that investors should short the stock. “SQNM has effectively met development and commercial launch milestones in the last 12 months and has driven significant test volume in the first six months of launch," the firm says.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|